SB 32-FN - AS AMENDED BY THE SENATE
02/09/2023 0291s
02/09/2023 0432s
2023 SESSION
23-0796
05/10
SENATE BILL 32-FN
AN ACT relative to the opioid abatement trust fund.
SPONSORS: Sen. Rosenwald, Dist 13; Sen. Gannon, Dist 23; Sen. Soucy, Dist 18; Rep. Nordgren, Graf. 12; Rep. Rochefort, Graf. 1; Rep. Tellez, Hills. 40; Rep. Telerski, Hills. 11; Rep. J. Murphy, Graf. 12
COMMITTEE: Health and Human Services
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill sets the amount of money needed in the opioid abatement trust fund balance to solicit applications. The bill also revises the duties of the opioid abatement advisory commission.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
02/09/2023 0291s
02/09/2023 0432s 23-0796
05/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Three
AN ACT relative to the opioid abatement trust fund.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Opioid Abatement Trust Fund. Amend RSA 126-A:84, II(b) to read as follows:
(b) All remaining funds shall be deposited into the opioid abatement trust fund as established by RSA 126-A:83, I to be distributed by the commissioner of the department of health and human services, with approval of the opioid abatement advisory commission. Funds may be awarded to a qualifying governmental entity or program for an approved use under RSA 126-A:86, I(b). The department shall solicit applications for qualifying projects at least once in any calendar year that the balance in the trust fund exceeds $5,000,000. The commission shall collaborate with the department as to how many times the department shall solicit applications in any calendar year in which the fund balance is at least $5,000,000, along with what amount above $5,000,000 for which to solicit applications.
2 New Hampshire Opioid Abatement Advisory Commission; Duties. Amend RSA 126-A:86, I to read as follows:
I. The opioid abatement advisory commission in coordination with the governor's commission on alcohol and other drugs, and in alignment with relevant state plans, shall:
(a) Consult with and advise the commissioner of the department of health and human services on the administration and management of the opioid abatement trust fund, and approve the selection of eligible fund recipients under RSA 126-A:83, II(b).
(b) Award grants, revolving loan funds, and matching funds to projects from the opioid abatement trust fund under RSA 126-A:83, I, in a manner consistent with the following criteria. All disbursements or grants shall require approval of the governor and executive council. Funds may be awarded if the project meets one of the following criteria:
(1) Reimburse the state and any political subdivision within the state for any portion of [the cost] its costs related to outpatient and residential opioid use disorder (OUD) and any co-occurring substance use disorder or mental health (SUD/MH) treatment services, including, but not limited to[, services provided to incarcerated individuals, Medication assisted treatment (MAT); abstinence-based treatment; treatment, recovery or other services provided by states, subdivisions, community health centers, or not-for-profit providers] costs for:
(A) Medications for substance use disorders (MSUD), abstinence-based treatment, treatment and recovery or other services provided by the state, any of its political subdivisions, community health centers, and not-for-profit providers, as long as no other reimbursement would otherwise have been received by any such recipient for such services; or
(B) Treatment provided to persons charged with crimes who are participating in a pre-trial services program, are being held on bail, are serving sentences in a state or county correctional facility, or are receiving treatment as a condition of probation, parole, or of a suspended or deferred sentence, as long as no other reimbursement would otherwise have been received by any such recipient for such services;
(2) Reimburse the state and any political subdivision for emergency response services related to OUD and any co-occurring SUD/MH issues provided by law enforcement and first responders;
(3) Support mobile intervention, treatment, and recovery services, offered by qualified professionals, for persons with OUD and any co-occurring SUD/MH issues or persons who have experienced an opioid overdose, including the prevention and/or treatment of secondary physical health conditions associated with, or exacerbated by, OUD;
(4) Support [detoxification] withdrawal management services for persons with OUD and any co-occurring SUD/MH issues, including [medical detoxification] medically monitored withdrawal management, referral to treatment or connections to other services;
(5) Reimburse the state and any political subdivision within the state for any portion of the cost of administering [naloxone] FDA-approved opioid reversal agents;
(6) Provide access to housing for people with OUD and any co-occurring SUD/MH issues, including supportive housing, recovery housing, or housing assistance programs;
(7) Provide or support transportation to treatment or recovery programs or services for persons with OUD and any co-occurring SUD/MH issues;
(8) Provide employment training or educational services for persons in treatment for or in recovery from OUD and any co-occurring SUD/MH;
(9) Create or support [centralizes] centralized call centers that provide information and connections to appropriate services and supports for persons with OUD and [an] any co-occurring SUD/MH issues;
(10) Improve oversight of opioid treatment programs (OTPs) to assure evidence-based[,]and/or evidence-informed practices;
(11) Provide scholarships and supports for certified addiction counselors and other mental and behavioral health providers involved in addressing OUD and any co-occurring SUD/MH issues, including, but not limited to, training, scholarships, fellowships, loan repayment programs, or other incentives for providers to work in rural or [undeserved] underserved areas of the state;
(12) Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of opioids through evidence-based[,] and/or evidence-informed programs or strategies;
(13) Support enhancements or improvements consistent with state law to the prescription drug monitoring program; [and]
(14) Support the education of law enforcement or other first responders regarding appropriate practices and precautions when dealing with fentanyl or other drugs.
(15) Support evidence-based and/or evidence-informed primary, secondary, and tertiary prevention programs and services, including efforts to promote healthy[, drug-free] lifestyles, reduce isolation, build skills and [confidence] resilience, and facilitate community-based prevention efforts[.];
(16) Support for public and non-public school programs and services for students with OUD and any co-occurring SUD/MH issues or who have been affected by OUD and any co-occurring SUD/MH issues within their family; and
(17) Support secondary and tertiary prevention through harm reduction programs.
3 Effective Date. This act shall take effect upon its passage.
23-0796
Amended 4/19/23
SB 32-FN- FISCAL NOTE
AS AMENDED BY THE SENATE (AMENDMENTS #2023-0291s and #2023-0432s)
AN ACT relative to the opioid abatement trust fund.
FISCAL IMPACT: [ ] State [ ] County [ ] Local [ X ] None
METHODOLOGY:
The Office of the Legislative Budget Assistant states that this bill, as amended, will have no impact on state, county, or local revenues or expenditures.
AGENCIES CONTACTED:
Department of Health and Human Services